共 146 条
[11]
Gal-Mor O(2019)Infections caused by Carbapenem-resistant Enterobacteriaceae: an update on therapeutic options Front Microbiol 10 133-692
[12]
Maor Y(2019)Novel beta-lactam-beta-lactamase inhibitor combinations: expectations for the treatment of carbapenem-resistant gram-negative pathogens Expert Opin Drug Metab Toxicol 15 675-773
[13]
Rahav G(2018)Ceftazidime-avibactam: a review in the treatment of serious gram-negative bacterial infections Drugs 78 770-1618
[14]
Patel G(2017)Treating complicated carbapenem-resistant enterobacteriaceae infections with ceftazidime/avibactam: a retrospective study with molecular strain characterisation Int J Antimicrob Agents 49 1615-364
[15]
Huprikar S(2016)Clinical outcomes, drug toxicity, and emergence of ceftazidime-avibactam resistance among patients treated for Carbapenem-resistant Enterobacteriaceae infections Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 63 355-123
[16]
Factor SH(2019)Efficacy of ceftazidime-avibactam salvage therapy in patients with infections caused by Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 68 118-241
[17]
Jenkins SG(2017)Clinical efficacy of ceftazidime/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 59 234-3175
[18]
Calfee DP(2016)Ceftazidime/avibactam and Ceftolozane/Tazobactam: second-generation beta-lactam/beta-lactamase inhibitor combinations Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 63 3170-2143
[19]
Villegas MV(2018)Effectiveness of ceftazidime/avibactam as salvage therapy for treatment of infections due to OXA-48 carbapenemase-producing Enterobacteriaceae J Antimicrob Chemother 73 2133-734
[20]
Pallares CJ(2015)Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study J Antimicrob Chemother 70 726-171